Showing results (761-770 of 843) with videos related to

Sort By:
Pageof 85
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy IndividualsNathan B Erdmann, Wilton B Williams, Stephen R Walsh, et al.
Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
The Journal of Experimental Medicine|June 3, 2009
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infectionJesus F Salazar-Gonzalez, Maria G Salazar, Brandon F Keele, et al.
Journal of Virology|July 29, 2011
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestorsMattia Bonsignori, Kwan-Ki Hwang, Xi Chen, et al.
Science Translational Medicine|November 2, 2021
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sophie Gobeil, et al.
Cell|January 5, 2024
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaquesKevin O Saunders, James Counts, Bhishem Thakur, et al.
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
JAMA|July 13, 2016
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical TrialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
Plos One|April 27, 2018
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvantYingxia Wen, Hung V Trinh, Christine E Linton, et al.
Pageof 85